Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 DiabetesNeha J. Pagidipati, Jairo Cruz, Matthew A. Cavender et al.|JAMA|2023Cited by 93
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J. Nelson, Christopher B. Granger, Neha J. Pagidipati et al.|Circulation|2021Cited by 79
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J. Nelson, Christopher B. Granger, Emily C. O’Brien et al.|JAMA Network Open|2022Cited by 73